Mannkind Corp
MNKD Nasdaq· Pharmaceutical Preparations
Last close · Oct 27, 2026
$3.29
KIRA · Stoqly’s AI analyst, in plain words
- Mannkind Corp had $349M of revenue in fiscal 2025, up 22.2% on the year before. Over five years, revenue changed +39.9% a year on average.
- Its operating margin was 11.1%, down 14.3 pts: of every 100 in sales, about 11 is left after running the business.
- Mannkind Corp made $5.9M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −37.4% a year.
- Free cash flow was $13.7M in fiscal 2025, 3.9% of revenue.
- Mannkind Corp owes $183M more than it holds in cash, about 3.6 years of operating profit.
Market cap
$1.0B
P/E
—
Revenue
$349M
Net income
$5.9M
Free cash flow
$13.7M
Operating margin
11.1%
Mannkind Corp in 30 seconds · fiscal 2025
Are sales growing?
+22.2%
Yes. Sales grew 22.2% last year.
Does it make a profit?
1.7%
A little. It keeps 1.7% of every sale as profit.
Does profit turn into cash?
3.9%
Partly. 3.9% of sales ends up as free cash.
Is debt under control?
3.6x
Heavy. Repaying its debt would take 3.6 years of operating profit.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Mannkind Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- MANNKIND CORP
- CIK
- 0000899460
Mannkind Corp · MNKD
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $75.4M | $99.8M | $199M | $286M | $349M |
| Revenue growth | 15.8% | 32.2% | 99.4% | 43.5% | 22.2% |
| Gross margin | 77.7% | 84.0% | 89.5% | 93.9% | 92.3% |
| Operating margin | −62.3% | −64.3% | 4.4% | 25.4% | 11.1% |
| Net income | −$80.9M | −$87.4M | −$11.9M | $27.6M | $5.9M |
| Net margin | −107.3% | −87.6% | −6.0% | 9.7% | 1.7% |
| Diluted EPS | −$0.32 | −$0.34 | −$0.04 | $0.10 | $0.02 |
| Cash | |||||
| Cash from operations | −$61.7M | −$80.7M | $34.1M | $42.5M | $18.3M |
| Capital expenditure | $11.5M | $7.6M | $42.4M | $9.7M | $4.6M |
| Free cash flow | −$73.2M | −$88.3M | −$8.3M | $32.8M | $13.7M |
| FCF margin | −97.0% | −88.5% | −4.2% | 11.5% | 3.9% |
| Share count change | 12.0% | 3.1% | 3.9% | 6.3% | 10.7% |
| Debt and strength | |||||
| Cash and short-term investments | $204M | $171M | $295M | $197M | $171M |
| Debt incl. finance leases | $382M | $378M | $373M | $36.1M | $355M |
| Shareholders' equity | −$209M | −$251M | −$246M | −$78.8M | −$51.0M |
| Net debt / EBITDA | — | — | 5.9x | −2.0x | 3.6x |
| Current ratio | 4.5x | 3.5x | 3.6x | 3.3x | 1.7x |
| Interest coverage | −3.1x | −4.3x | 0.6x | 6.1x | 2.8x |
| Returns and quality | |||||
| Return on capital | — | — | — | — | 29.3% |
| Piotroski F-score | 5 | 3 | 7 | 7 | 3 |
| Altman Z'' | −29.7 | −33.7 | −18.7 | −22.3 | −11.9 |
Insiders bought, 12 months
$0.3M
1 insider
Insiders sold, 12 months
$3.3M
5 insiders
Of sales under plans
100%
$3.3M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Mannkind Corp · MNKD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.29 a share, the company is worth $1.0B.
Source: SEC EDGAR XBRL filings (CIK 0000899460). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.